In this study, typical cases of blood stasis syndrome of coronary heart disease are selected, by using microRNA chip, cDNA microarray and other bioinformatics technologies to filter and verify related miRNA and its target gene of Coronary Heart disease. Meanwhile, intervene by Xuesaitong soft capsules to investigate related miRNA and its target gene of Coronary Heart disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
70
Xuesaitong soft capsule, soft capsule, Ingredients:PNS, Specification:0.33 per bag, once take two pills and twice a day during a month.
Xuesaitong soft capsule Placebo, soft capsule, once take two pills and twice a day during a month.
Guang'an men Hispital
Beijing, Beijing Municipality, China
RECRUITINGthe change of Cycle threshold of relational microRNA in coronary artery disease with unstable angina
The change of Cycle threshold of relational microRNA in coronary artery disease with unstable angina by real RT-PCR.
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.